newsfilter
← Latest News
GlobeNewswire·

Akouos Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Highlights

- Advanced toward planned IND submissions for AK-OTOF in the first half of 2022 and AK-antiVEGF in 2022 - Presented data at ARO demonstrating potential of precision genetic medicine platform to address a broad range of inner ear conditions - Expand